Display options
Share it on

PLoS One. 2021 Nov 30;16(11):e0260597. doi: 10.1371/journal.pone.0260597. eCollection 2021.

The use of heuristics in genetic testing decision-making: A qualitative interview study.

PloS one

Bettina Maria Zimmermann, David Martin Shaw, Bernice Elger, Insa Koné

Affiliations

  1. Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
  2. Institute of History and Ethics in Medicine, School of Medicine, Technical University of Munich, Munich, Germany.
  3. Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
  4. Center for Legal Medicine, University of Geneva, Geneva, Switzerland.

PMID: 34847204 PMCID: PMC8631642 DOI: 10.1371/journal.pone.0260597

Abstract

BACKGROUND: Decision-making concerning predictive genetic testing for hereditary cancer syndromes is inherently complex. This study aims to investigate what kind of complexities adults undergoing genetic counseling in Switzerland experience, how they deal with them, and what heuristics they use during the decision-making process.

METHODS: Semi-structured qualitative interviews with eighteen Swiss adults seeking genetic counseling for hereditary cancer syndrome genetic testing and two counseling physicians were conducted and analyzed using a grounded theory approach.

RESULTS: Counselees stated that once they were aware of their eligibility for genetic testing they perceived an inevitable necessity to make a decision in a context of uncertainties. Some counselees perceived this decision as simple, others as very complex. High emotional involvement increased perceived complexity. We observed six heuristics that counselees used to facilitate their decision: Anticipating the test result; Focusing on consequences; Dealing with information; Interpreting disease risk; Using external guidance; and (Re-)Considering the general uncertainty of life.

LIMITATIONS: Our findings are limited to the context of predictive genetic testing for hereditary cancer syndromes. This qualitative study does not allow extrapolation of the relative frequency of which heuristics occur.

CONCLUSIONS: The use of heuristics is an inherent part of decision-making, particularly in the complex context of genetic testing for inherited cancer predisposition. However, some heuristics increase the risk of misinterpretation or exaggerated external influences. This may negatively impact informed decision-making. Thus, this study illustrates the importance of genetic counselors and medical professionals being aware of these heuristics and the individual manner in which they might be applied in the context of genetic testing decision-making. Findings may offer practical support to achieve this, as they inductively focus on the counselees' perspective.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Nurse Res. 2006 Jul 1;13(4):84 - PubMed
  2. Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):98-107 - PubMed
  3. Qual Health Res. 2006 Jan;16(1):97-118 - PubMed
  4. J Health Psychol. 2002 Jul;7(4):469-84 - PubMed
  5. Med Health Care Philos. 2007 Dec;10(4):417-31 - PubMed
  6. J Natl Compr Canc Netw. 2019 Sep 1;17(9):1032-1041 - PubMed
  7. Mol Aspects Med. 2019 Oct;69:10-26 - PubMed
  8. Med Humanit Rev. 1987 Jan;1(1):78-82 - PubMed
  9. Health Commun. 2011 Oct;26(7):667-75 - PubMed
  10. Health Psychol. 2005 Jul;24(4S):S35-40 - PubMed
  11. Ann Behav Med. 2006 Feb;31(1):45-52 - PubMed
  12. Clin Ter. 2011;162(5):e141-4 - PubMed
  13. Med Decis Making. 2015 May;35(4):539-57 - PubMed
  14. Patient Educ Couns. 2018 Mar;101(3):422-427 - PubMed
  15. J Med Ethics. 2004 Oct;30(5):435-9; discussion 439-40 - PubMed
  16. Psychooncology. 2005 Jan;14(1):34-48 - PubMed
  17. Sociol Health Illn. 2003 Nov;25(7):838-65 - PubMed
  18. JAMA Oncol. 2015 Oct;1(7):943-51 - PubMed
  19. Health Expect. 2008 Sep;11(3):220-31 - PubMed
  20. Soc Sci Med. 2016 Aug;163:21-7 - PubMed
  21. Health Care Anal. 2007 Mar;15(1):13-23 - PubMed
  22. Psychooncology. 2012 Jun;21(6):611-7 - PubMed
  23. Cancer Nurs. 2017 Sep/Oct;40(5):386-393 - PubMed
  24. Eur J Hum Genet. 2013 Mar;21(3):256-60 - PubMed
  25. Nat Rev Cancer. 2016 Sep;16(9):599-612 - PubMed
  26. J Genet Couns. 2007 Aug;16(4):419-32 - PubMed
  27. Annu Rev Psychol. 2011;62:451-82 - PubMed
  28. Ann Behav Med. 2015 Aug;49(4):616-21 - PubMed
  29. J Genet Couns. 2017 Apr;26(2):232-243 - PubMed
  30. Community Genet. 2003;6(4):224-34 - PubMed
  31. Eur J Hum Genet. 2020 Aug;28(8):1010-1019 - PubMed
  32. Am J Pathol. 2013 Oct;183(4):1038-1051 - PubMed
  33. J Genet Couns. 2017 Oct;26(5):999-1007 - PubMed
  34. Int J Qual Health Care. 2007 Dec;19(6):349-57 - PubMed
  35. Tumori. 2015 Jul 24;101(4):e113-4 - PubMed
  36. J Pers Soc Psychol. 2001 Dec;81(6):973-88 - PubMed
  37. Qual Health Res. 2011 Apr;21(4):502-19 - PubMed
  38. J Genet Couns. 2009 Jun;18(3):252-64 - PubMed
  39. Behav Med. 2005 Fall;31(3):93-105 - PubMed
  40. Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):728-35 - PubMed
  41. Med Decis Making. 2011 Nov-Dec;31(6):828-38 - PubMed
  42. Bioethics. 2021 Feb;35(2):199-206 - PubMed
  43. Genet Med. 2014 Jul;16(7):516-21 - PubMed
  44. Patient Educ Couns. 1998 Sep;35(1):53-62 - PubMed
  45. Oncotarget. 2017 Jan 10;8(2):1957-1971 - PubMed
  46. Health Psychol. 2013 Nov;32(11):1158-69 - PubMed
  47. Patient Educ Couns. 2018 Dec;101(12):2083-2089 - PubMed
  48. J Health Psychol. 2002 Mar;7(2):131-44 - PubMed
  49. BMJ. 2001 Apr 28;322(7293):1052-6 - PubMed
  50. Genet Med. 2014 Jul;16(7):522-8 - PubMed

Publication Types